Serum and Urine Uric Acid as a Biomarker in Osteoarthritis

Jae-Bum Jun

doi:10.4078/jrd.2020.27.2.75

Journal List > J Rheum Dis > v.27(2) > 1144360

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jun: Serum and Urine Uric Acid as a Biomarker in Osteoarthritis

Editorial

J Rheum Dis 2020;27(2):75-77.

Published online: 31 October 2020

DOI: https://doi.org/10.4078/jrd.2020.27.2.75

Serum and Urine Uric Acid as a Biomarker in Osteoarthritis

Jae-Bum Jun, M.D., Ph.D.

Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea

Corresponding to: Jae-Bum Jun http://orcid.org/0000-0002-0208-0505 Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. E-mail: junjb@hanyang.ac.kr

Received 17 February 2020 Accepted 19 February 2020

This is a Open Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

1. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010; 5:463–6.

2. International Programme on Chemical Safety. Biomarkers and risk assessment: concepts and principles [Internet]. Geneva: World Health Organization;c1993. [cited 2020]. Available from:. http://www.inchem.org/documents/ehc/ehc/ehc155.htm.

3. Mobasheri A. Osteoarthritis year 2012 in review: biomarkers. Osteoarthritis Cartilage. 2012; 20:1451–64.

4. Watt FE. Osteoarthritis biomarkers: year in review. Osteoarthritis Cartilage. 2018; 26:312–8.

5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003; 41:1183–90.

6. Borges RL, Ribeiro AB, Zanella MT, Batista MC. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep. 2010; 12:113–9.

7. Acheson RM, Collart AB. New Haven survey of joint diseases. XVII. Relationship between some systemic characteristics and osteoarthrosis in a general population. Ann Rheum Dis. 1975; 34:379–87.

8. Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, et al. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A. 2011; 108:2088–93.

9. Ding X, Zeng C, Wei J, Li H, Yang T, Zhang Y, et al. The associations of serum uric acid level and hyperuricemia with knee osteoarthritis. Rheumatol Int. 2016; 36:567–73.

10. Ma CA, Leung YY. Exploring the link between uric acid and osteoarthritis. Front Med (Lausanne). 2017; 4:225.

11. Neogi T, Krasnokutsky S, Pillinger MH. Urate and osteoarthritis: evidence for a reciprocal relationship. Joint Bone Spine. 2019; 86:576–82.

12. Krasnokutsky S, Oshinsky C, Attur M, Ma S, Zhou H, Zheng F, et al. Serum urate levels predict joint space narrowing in non-gout patients with medial knee osteoarthritis. Arthritis Rheumatol. 2017; 69:1213–20.

13. Xiao L, Lin S, Zhan F. The association between serum uric acid level and changes of MRI findings in knee osteoarthritis: a retrospective study (A STROBE-compliant article). Medicine (Baltimore). 2019; 98:e15819.

14. Kim SK, Jung UH, Choe JY. Clinical usefulness of uric acid as a biomarker for knee osteoarthritis: a comparative analysis with plain radiography and musculoskeletal ultrasound. J Rheum Dis. 2020; 27:51–60.

15. Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019; 37(Suppl 120):3–6.

16. Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in Osteoarthritis: A systematic review and meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2019 Jun 17; [Epub].DOI: DOI: 10.1002/acr.24008.

17. Choi S, Moon SJ, Kang EJ, Lee KH. Validity of random urinary uric acid-to-creatinine ratio for estimating 24-hour urine uric acid excretion in patients with gout. Ann Rheum Dis. 2018; 77(Suppl 2):664–5.

18. Moriwaki Y, Yamamoto T, Takahashi S, Yamakita J, Tsutsumi Z, Hada T. Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout. J Rheumatol. 2001; 28:1306–10.

19. Kannangara DR, Ramasamy SN, Indraratna PL, Stocker SL, Graham GG, Jones G, et al. Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients. Arthritis Res Ther. 2012; 14:R189.

20. Yu KH, Luo SF, Tsai WP, Huang YY. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion. Rheumatology (Oxford). 2004; 43:1541–5.

21. Son CN, Bang SY, Kim JH, Choi CB, Kim TH, Jun JB. Caspase-1 level in synovial fluid is high in patients with spondyloarthropathy but not in patients with gout. J Korean Med Sci. 2013; 28:1289–92.

TOOLS

Similar articles